We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Reducing Non-Core Trial Procedures Could Save Billions: Tufts Researcher
Reducing Non-Core Trial Procedures Could Save Billions: Tufts Researcher
July 18, 2012
Drugmakers are paying anywhere from $3 billion to $5 billion annually for clinical trial procedures that may not be necessary, a new study concludes.